Cognos Therapeutics Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $55.2K
Latest Deal Amount

Cognos Therapeutics General Information

Description

Developer of diagnostic devices designed to advance the diagnosis and treatment of neuropathic diseases. The company's devices focus on diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma occurrences as well as other central nervous system afflictions, enabling doctors to detect diseases, monitor their patients, and deliver medicines as per requirements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Drug Delivery
Monitoring Equipment
Primary Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States
+1 (310) 000-0000

Cognos Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) 12-Oct-2021 $55.2K 00.00 Completed Generating Revenue
5. Angel (individual) 15-Jul-2021 00000 00.000 Completed Generating Revenue
4. Angel (individual) 21-May-2021 00.000 00.000 Completed Pre-Clinical Trials
3. Angel (individual) 29-May-2018 00000 00000 Completed Startup
2. Angel (individual) 20-Apr-2016 $48K $208K Completed Startup
1. Angel (individual) 07-Dec-2015 $160K $160K Completed Startup
To view Cognos Therapeutics’s complete valuation and funding history, request access »

Cognos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of diagnostic devices designed to advance the diagnosis and treatment of neuropathic diseases. The company's d
Diagnostic Equipment
Inglewood, CA
7 As of 2021
00.00
0000000000 00.00

000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
000000000000000
North Chicago, IL
000000 As of 0000
000.00
000000000 000.00

00000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
00000 0000000000 0000000000 0000000
Minneapolis, MN
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cognos Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott Corporation North Chicago, IL 000000 000.00 000000000 000.00
000000000 Corporation Minneapolis, MN 00000 00000000
You’re viewing 2 of 2 competitors. Get the full list »

Cognos Therapeutics Patents

Cognos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021512165-A Intratumoral delivery of bortezomib Pending 29-Jan-2018 000000000
US-20210106522-A1 Intratumoral delivery of bortezomib Pending 29-Jan-2018 0000000000
EP-3746065-A1 Intratumoral delivery of bortezomib Pending 29-Jan-2018 0000000000
US-10786155-B2 Skull-mounted drug and pressure sensor Active 13-May-2016 0000000000
US-20170325685-A1 Skull-mounted drug and pressure sensor Granted 13-May-2016 A61B5/0031 0
To view Cognos Therapeutics’s complete patent history, request access »

Cognos Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Frank Adell Chief Executive Officer, President & Board Member
Thomas Lobl Ph.D Chief Operating Officer
Winston Wu Chief Technology Officer, Senior Vice President of Product Development & Board Member
Ian Welsford Ph.D Chief Regulatory and Compliance Office
Josh Shachar Chief Innovation Officer & Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

Cognos Therapeutics Board Members (9)

Name Representing Role Since
Eli Gang Cognos Therapeutics Board Member 000 0000
Frank Adell Cognos Therapeutics Chief Executive Officer, President & Board Member 000 0000
Josh Shachar Cognos Therapeutics Chief Innovation Officer & Board Member 000 0000
Richard Lerner MD Cognos Therapeutics Board Member 000 0000
Roger Kornberg Ph.D Cognos Therapeutics Co-Founder, Strategic Advisor 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Cognos Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial